Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information
The Pharmacist’s Guide to Patient Identification, Testing, and Antiviral Use.
Choose from the criteria below to find an activity that fits you best.
|Co-produced by ProCE and the Society of Infectious Diseases Pharmacists (SIDP).|
While strides have been made to slow the HIV epidemic, pockets of the population are still disproportionately affected by HIV progression, undertreatment, or disruptions in linkage to care. Underserved people living with HIV face unique challenges to receiving appropriate HIV screening and treatment, such as discrimination in the health-system or their communities, low health literacy, or barriers to continuity of care. This activity will examine the sociocultural challenges and root causes of the many disparities that are present in the US for people living with HIV. The pharmacist’s role in overcoming obstacles associated with these challenges will be discussed.
The target audience for this activity includes pharmacists. At the completion of this activity, the participant will be able to:
Melissa Badowski, PharmD, MPH, FCCP, BCIDP, BCPS, AAHIVP
Clinical Associate Professor
Section of Infectious Diseases Pharmacotherapy, Dept. of Pharmacy Practice
University of Illinois at Chicago, College of Pharmacy
Milena Murray, PharmD, MSc, BCIDP, AAHIVP
Associate Professor of Pharmacy Practice
Midwestern University College of Pharmacy
HIV/ID Clinical Pharmacist
Northwestern Memorial Hospital
Downers Grove, Illinois
Jason J. Schafer, PharmD, MPH, BCPS AQ-ID, BCIDP, AAHIVP
Professor and Vice Chair
Department of Pharmacy Practice
Jefferson College of Pharmacy
Thomas Jefferson University
Release Date: December 8, 2020
Expiration Date: December 31, 2021
This activity is jointly provided by Pro CE, LLC and the Society of Infectious Diseases Pharmacists (SIDP). Pro CE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-503-H02-P has been assigned to this home study knowledge-based activity. This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Badowski has no relevant commercial or financial relationships to disclose. Dr. Murray has received honorarium as a speaker for Merck and as an advisory board member for Theratechnologies. Dr. Schafer has received a consulting fee as an advisory board member from Merck and ViiV, and a research grant as investigator for Merck and Gilead.
This activity is supported by an educational grant from Merck.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.